Management Buyout at Molecular Dimensions

Another deal to announce. We have recently helped Tony Savill, CEO of Suffolk based Molecular Dimensions, to acquired the business through an amicable management buyout from existing shareholders.

Molecular Dimensions is a world leading supplier of modern screens, reagents, other consumables and instrumentation for protein structure determination by X-ray crystallography.  Headquartered in Newmarket it has offices in the USA and distribution in Asia.  Founded in 1998 to provide specialist products for crystallographers across the world, it has grown through alliances with leading scientists aimed at developing and commercializing innovative ideas.  Current alliances include the MRC Laboratory of Molecular Biology Cambridge, Imperial College London, and the York Structural Biology Laboratory, University of York.

Molecular-dimensions-mbo-compressed Molecular Dimensions offers the most innovative range of products from the latest developments in structural biology research.  The company currently has over 20 projects at various stages of development from new screens and reagents for crystal growth, new laboratory plastic-ware, to a range of instrumentation through an exclusive collaboration with a spin-off company from a German university.  The company has launched two unique products already this year; one for screening temperature as a crystal growth parameter, and a new device for growing crystals and analyzing them ‘in-situ’ in capillaries.

Tony has been MD of the business since its formation as an associated company ofStratech Scientific Limited.   Stratech, which was founded over 26 years ago, is a distributor of innovative and specialist life science research tools and  supplies one of the largest ranges of primary and secondary antibodies.  The management buyout of Molecular Dimensions follows a strategic review and should allow both businesses to grow through greater focus on their respective different markets.

As is often the case following a buyout an independent Molecular Dimensions will benefit from increased market focus.  It is also good to see bank funding once more becoming available for such transactions”. 

Legal advice to the buyout team was provided by Claire Clarke and Stephen Hamilton at Mills & Reeve in Cambridge.    Finance for the transaction was arranged by Steve Cooper of HSBC Cambridge’s technology team.